Supplementation with a dietary multicomponent (Lafergin(®)) based on Ferric Sodium EDTA (Ferrazone(®)) results of an observational study

Supplementation with a dietary multicomponent (Lafergin(®)) based on Ferric Sodium EDTA (Ferrazone(®)) : results of an observational study

During pregnancy, iron deficiency anemia is recognized as a specific risk factor for both adverse maternal and perinatal outcome. We decided to test the hypothesis that the daily administration of Lafergin(®), a dietary multicomponent based on Ferrazone(®) (Ferric Sodium EDTA), Lactoferrin, Vitamin...

Ausführliche Beschreibung

Bibliographische Detailangaben
Veröffentlicht in:Journal of prenatal medicine. - 2007. - 9(2015), 1-2 vom: 01. Jan., Seite 1-7
1. Verfasser: Cignini, Pietro (VerfasserIn)
Weitere Verfasser: Mangiafico, Lucia, Padula, Francesco, D'Emidio, Laura, Dugo, Nella, Aloisi, Alessia, Giorlandino, Claudio, Vitale, Salvatore Giovanni
Format: Online-Aufsatz
Sprache:English
Veröffentlicht: 2015
Zugriff auf das übergeordnete Werk:Journal of prenatal medicine
Schlagworte:Journal Article anemia birth wight iron supplementation pregnancy
Beschreibung
Zusammenfassung:During pregnancy, iron deficiency anemia is recognized as a specific risk factor for both adverse maternal and perinatal outcome. We decided to test the hypothesis that the daily administration of Lafergin(®), a dietary multicomponent based on Ferrazone(®) (Ferric Sodium EDTA), Lactoferrin, Vitamin C and Vitamin B12, from first trimester of pregnancy until the end of gestation, may significantly reduce, in anemic women, the severity of anemia compared to controls who received ferrous sulfate or liposomal iron
Beschreibung:Date Completed 26.02.2016
Date Revised 29.09.2020
published: Print
Citation Status PubMed-not-MEDLINE
ISSN:1971-3282
DOI:10.11138/jpm/2015.9.1.001